Clinical Notes: Canadian testicular cancer guidelinesGuidelines developed on diagnosis, management of germ cell testicular cancer. Clinical Notes: New vitamin D guidelinesOsteoporosis Canada updates recommendations for optimal vitamin D intake. Clinical Notes: Triptan safety in pregnancy Exposure to sumatriptan during pregnancy does not appear increase risk of birth defects: study Dealing with grievances under new regulations With regulation, expected to come soon, techs will be held to the same standards pharmacists are accustomed to and will be accountable to the Ontario College of Pharmacists (OCP). Drug News: Finacea, FluMist, Intanza Finacea: new topical treatment for rosacea; FluMist: first intranasal flu vaccine; Intanza: first intradermal flu vaccine. Ethics and Issues: How to be a leader in practice change Advice for ‘regular pharmacists’ who want to be leaders in practice change. Every day should be a vitamin D day There have probably been more reports on vitamin D this year than on any other health issue. Here’s why Letter: What do pharmacists want? Why are we providing our professional services for less than it costs to cover our expenses? Letter: Questioning the role of DPP-4 inhibitors A reader comments on the role of DPP-4 inhibitors in the management of type 2 diabetes. Making the grade Tech takes on teaching duties. Mapping out this year’s pharmacy trends Our annual Trends & Insights Survey of Retail Pharmacists paints a picture of pharmacy practice amidst volatility. Medication Forum: SGLT2 inhibitors for type 2 diabetes The potential role of SGLT2 inhibitors in the management of type 2 diabetes. First Previous 1854 1855 1856 1857 1858 Next Last
